Introduction
============

Stickler syndrome (OMIM [108300](http://omim.org/entry/108300), [604841](http://omim.org/entry/604841), [184840](http://omim.org/entry/184840)) is a common hereditary connective tissue disorder of fibrillar collagen. Collagen alterations in patients with Stickler syndrome contribute to bilateral ophthalmological symptoms, as well as systemic effects, such as a distinctive facial appearance (orofacial features), hearing loss, and joint problems \[[@r1]\]. Typical ophthalmological findings of this disease include congenital high myopia, abnormal vitreous, glaucoma, cataracts, and retinal detachment. The phenotype of Stickler syndrome is complicated and develops over a lifetime. According to previous reports, approximately 55--73% of Caucasian patients with a clinical diagnosis of Stickler syndrome previously suffered retinal detachment \[[@r2]-[@r4]\]. Retinal detachment can lead to a high incidence of blindness and severely decreases the patient's quality of life. Prophylactic retinopexy, such as cryotherapy, significantly reduces the risk of retinal detachment and blindness from Stickler syndrome \[[@r3],[@r5],[@r6]\]. Therefore, an early clinical diagnosis is important for improving prognosis. Nevertheless, the heterogeneous clinical phenotype may present a challenge, particularly for patients with only ocular phenotypes.

The estimated prevalence rate of Stickler syndrome is 1 in every 10,000 newborns \[[@r7]\]. According to the locus heterogeneity and differences in the vitreous phenotype, Stickler syndrome is primarily classified into six subtypes. Types 1 and 2 are caused by mutations in the *COL2A1* (OMIM [120140](http://omim.org/entry/120140)) and *COL11A1* (OMIM [120280](http://omim.org/entry/120280)) genes, respectively. It is estimated that these two genes are responsible for more than 95% of the mutations in patients with Stickler syndrome ([HGMD](http://www.hgmd.cf.ac.uk/ac/index.php), last updated in March 2015).

Advances in sequencing technologies may allow for more efficient diagnosis of disease by combining analyses of phenotypes and gene mutations. *COL2A1* and *COL11A1* are common candidate genes for Stickler syndrome, and both are related to the form of Stickler syndrome with an obvious ocular phenotype. Thus, by evaluating these two genes, patients may obtain an early diagnosis, and early prophylactic measurements may be obtained.

Several surveys of the nosological characteristics of Stickler syndrome have evaluated mutations in the *COL2A1* and *COL11A1* genes. These studies revealed the genotype-phenotype correlation of Caucasian patients with Stickler syndrome for types 1 and 2 \[[@r4],[@r8]-[@r10]\]. Hoornaert reported that compared to mutation-negative patients, patients with a *COL2A1* mutation had more frequent phenotypes of vitreous anomalies and retinal detachment. In addition, more than 90% of *COL2A1* mutations are predicted to result in nonsense-mediated decay \[[@r4]\]. However, Liberfarb suggested that it may be difficult to predict the prevalence of certain clinical features for various inter- and intrafamilies based on the genotype \[[@r9]\]. Moreover, although Rose established new diagnostic criteria with high sensitivity and specificity for Stickler syndrome \[[@r10]\], few research studies have involved Chinese patients with Stickler syndrome with an initial diagnosis of an ocular phenotype. In this study, the *COL2A1* and *COL11A1* genes were analyzed in 16 Chinese probands with Stickler syndrome who presented with an initial ocular phenotype. The purpose of this study was to identify the spectrum of candidate genes and the genotype-phenotype correlation in Chinese patients with Stickler syndrome.

Methods
=======

Patients
--------

Sixteen unrelated Chinese patients with Stickler syndrome were recruited from the Pediatric and Genetic Clinic of Zhongshan Ophthalmic Center between 2007 and 2015. Before venous blood and clinical data were collected, written informed consent conforming to the tenets of the Declaration of Helsinki was obtained from the participants or their guardians. Studies were performed with approval from the Institutional Review Board of the Zhongshan Ophthalmic Center. Patients were diagnosed mainly according to the criteria of Stickler syndrome used by Snead and Yates \[[@r11]\]. The ocular phenotype was diagnosed if the following criteria were present: (1) a vitreous anomaly, (2) myopia with onset before the age of 6 years, and (3) rhegmatogenous retinal detachment or paravascular pigmented lattice degeneration. In addition, at least two of the following features had to be present: (4) hypermobility with an abnormal Beighton score, (5) sensorineural hearing defect, and (6) midfacial dysplasia. A full ophthalmic examination was performed, including a best-corrected visual acuity assessment, slit-lamp biomicroscopy, fundus photography, B-ultrasound scan, retinoscopy with cycloplegia, and the IOL Master. Systemic examination included an audiogram, a musculoskeletal examination with skeletal X-rays of the long bones, and Beighton scoring. For children who were too young to finish the audiogram, the brainstem auditory evoked potential was tested.

Mutation screening
------------------

Genomic DNA was extracted from leukocytes obtained from peripheral blood samples, as previously described \[[@r12]\]. After lysis of the whole blood, genomic DNA was extracted from leukocytes of the peripheral venous blood with phenol-chloroform extraction and ethanol precipitation. The *COL2A1* gene ([NM_001844.4](http://www.ncbi.nlm.nih.gov/nuccore/NM_001844.4)) was evaluated first. If the *COL2A1* gene was negative, then the *COL11A1* gene ([NM_080629.2](http://www.ncbi.nlm.nih.gov/nuccore/NM_080629.2)) was evaluated. The primer pairs were designed using [primer3](http://primer3.ut.ee/) \[[@r13]\]; see Appendix 1 for all primers used for amplification and sequencing. The products from individual exons were sequenced using the ABI BigDye Terminator cycle sequencing kit v3.1 and an ABI 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). Then, consensus sequences were used to identify variations in the sequencing results with a sequencing program (Lasergene SeqMan II; DNASTAR, Madison, WI). Repeated sequencing was performed for every variant to confirm the result. Frequencies of variants were determined from the [1000 Genomes database](http://browser.1000genomes.org/index.html) and exome variant server ([EVS](http://evs.gs.washington.edu/EVS/)), removing minor allele frequency (MAF) values that were greater than 0.0002. The frequency was based on the incidence of Stickler syndrome (1/10,000) and the fraction of heterozygotes in Hardy--Weinberg equilibrium. Any variation detected in the patients was further evaluated by sequencing 96 healthy individuals as a control. The [PolyPhen-2](http://genetics.bwh.harvard.edu/pph2/) \[[@r14]\] and [SIFT](http://sift.jcvi.org/) \[[@r15]\] online tools were used to predict the pathogenicity of missense mutations on the encoding regions. The pathogenicity of splice-site changes in the introns and synonymous variants in the exons were predicted using the Splice Site Prediction program with Neural Network ([BDGP](http://www.fruitfly.org/seq_tools/splice.html)) \[[@r16]\]. Segregation analyses of mutations were performed for the available family members.

Multiplex ligation-dependent probe amplification
------------------------------------------------

Multiplex ligation-dependent probe amplification (MLPA) assays were designed by MRC-Holland (Amsterdam, the Netherlands). There are a total of 28 *COL2A1* exon-specific probes and 57 *COL11A1* exon-specific probes (see Appendix 2 or the [WebForm manufacturer's website](http://www.mrc-holland.com/WebForms/WebFormMain.aspx) for detailed exon specific probes in each kit). The MLPA kits and cDNA reference sequences were [NM_001844.4](http://www.ncbi.nlm.nih.gov/nuccore/NM_001844.4) for *COL2A1* and [NM_080629.2](http://www.ncbi.nlm.nih.gov/nuccore/NM_080629.2) for *COL11A1*. MLPA was performed according to the manufacturer's protocol ([WebForm](http://www.mrc-holland.com/WebForms/WebFormMain.aspx)). Analysis of the results was conducted with the GeneMarker software ([Soft Genetics](http://www.softgenetics.com), State College, PA). All three MLPA probe sets were used to initially screen for duplications or deletions in *COL2A1* and *COL11A1* of the probands.

Results
=======

Molecular findings
------------------

The *COL2A1* gene screen identified five potential pathogenic variants in six of 16 Stickler syndrome families. Of these five mutations, three were novel (c.85C\>T, c.3356delG, c.3401delG), and two were previously reported (c.1693C\>T, c.2710C\>T) \[[@r5],[@r17],[@r18]\]. Both missense mutations were arginine to cysteine mutations in the X position of the Gly-X-Y triplet. Putative pathogenic mutations were absent in the *COL2A1* gene in the remaining ten probands. The mutation results for the *COL2A1* gene are summarized in [Table 1](#t1){ref-type="table"}.

###### Mutations in *COL2A1* identified in the probands with Stickler syndrome.

  Family ID        Exon   Mutation     Amino acid change      Inheritance patterns   MAF (%) in 1000G/ EVS   Reported
  ---------------- ------ ------------ ---------------------- ---------------------- ----------------------- ----------------------------------------------------------------
  QT1527           1      c.85C\>T     p.(Gln29\*)            SC                     NA/NA                   No
  QT851            48     c.3356delG   p.(Gly1119Glufs\*11)   AD                     NA/NA                   No
  QT1589           48     c.3401delG   p.(Gly1134Alafs\*93)   AD                     NA/NA                   No
  QT1016 /QT1791   26     c.1693C\>T   p.(Arg565Cys)          AD                     NA/NA                   Richards et al. 2000 \[[@r5]\]
  HM470            41     c.2710C\>T   p.(Arg904Cys)          SC                     NA/NA                   Ballo et al. 1998 \[[@r17]\]; Nagendran et al. 2012 \[[@r18]\]

Note: AD=autosomal dominant; SC=sporadic case; NA=these variants were absent from the 1000 Genome and the Exome Variant Server database.

All three novel variants were premature termination codon mutations, which were considered most likely pathogenic \[[@r19]\]. These mutations were absent in the 1000 Genomes, EVS cohort, and 96 healthy individuals. Putative pathogenic variants were not detected in the *COL11A1* gene. None of the gross indels in *COL2A1* or *COL11A1* was found in the 16 probands using MLPA. The sequence maps, pedigrees, and cosegregation analyses of the three families with novel mutations of *COL2A1* are shown in [Figure 1](#f1){ref-type="fig"}.

![The sequence maps, pedigrees, and cosegregation analyses of three families with novel mutations in *COL2A1*.](mv-v22-697-f1){#f1}

Clinical status
---------------

Detailed family histories and clinical data were analyzed for a total of 16 probands (four female patients and 12 male patients) with Stickler syndrome. Nine patients had family histories of autosomal dominance, and seven were sporadic cases. A total of 15 patients presented at the ophthalmic department with an initial phenotype of myopia. Five patients had developed unilateral or bilateral retinal detachment. The ages of initial diagnosis of Stickler syndrome ranged from 3 to 53 years. Monocular or binocular rhegmatogenous retinal detachment developed in 31.3% of the patients (5/16) at a median age of 11.3 years (ranging from 1.5 to 28 years old). The early onset of moderate or high myopia (\<--4.00 D) was found in 93.8% of patients (15/16) before the age of 6 years old. A total of 37.5% of patients (6/16) developed cataracts before their third decade, and two developed cataracts after retinal detachment. The clinical phenotypes of the patients with observed mutations are summarized in Appendix 3. The clinical phenotypes of other probands without any mutations in *COL2A1* or *COL11A1* are summarized in Appendix 4.

One of the three novel mutations was a nonsense mutation, c.85C\>T (p.Gln29\*), in proband QT1527, and the other two novel mutations were small deletions in exon 48, c.3356delG (p.Gly1119Glufs\*11) in proband QT851 and c.3401delG (p.Gly1134Alafs\*93) in proband QT1589, and all three variants resulted in truncation. QT1527 was a sporadic case; this female patient had severe myopia (−13.75 D/−17.50 D) and experienced retinal detachment of the right eye at the age of 28 years. Fundus examination detected perivascular retinal degeneration that developed into a horseshoe hole. She had prominent eyes, a low nasal bridge, and micrognathia. No other systemic phenotypes were detected. QT851 was a young male patient who developed retinal detachment in both eyes before 1.5 years of age. After vitrectomy, he suffered severe cataract in both eyes, and it was difficult to observe his vitreous anomaly. His Beighton scale score was 1/1, and no arthropathy or hearing loss was detected. His father also had a history of bilateral retinal detachments, and his sister had high myopia (−5.00 D/−6.00 D) at the age of 4.5 years. All patients in the QT851 family had flat faces with micrognathia. QT1589 showed moderate myopia at age 6; this female patient showed vitreous membranous anomalies. She had no complaints about pain in joints, although the X-ray examination showed epiphyseal dysplasia of both wrists. Joint hypermobility was also present. Her Beighton scale score was 7/7. Her midfacial dysplasia was obvious, and her mother also had bilateral retinal detachments. There was no evidence of midline clefting in all patients with detected *COL2A1* mutations.

With the exception of midfacial dysplasia, only four probands had systemic phenotypes. X-rays revealed that QT1589 and HM964 had epiphyseal dysplasia in both wrists. QT1211 had had mixed hearing loss since childhood. QT1553 was a sporadic case and upon a general physical checkup was found to have a pigeon chest and a protuberant abdomen without tenderness. In the four probands with obvious systemic phenotypes, the *COL2A1* mutation was detected only in QT1589. Although all pediatric patients had the facial phenotype of prominent eyes and low nasal bridges, and QT851, QT1791, and QT1589 (who had detected mutations in *COL2A1*) all had micrognathia, whereas no mutations in *COL2A1* or *COL11A1* were detected in QT1553 and HM964 who were hypognathous. Both groups corresponded to the diagnosis standards of Stickler syndrome. The typical phenotypes observed in the patients are shown in [Figure 2](#f2){ref-type="fig"}.

![Typical clinical phenotypes of Chinese patients with Stickler syndrome. **A**: Vitreous opacities and retinal detachment in QT1547. **B**: Membrane vitreous abnormalities in QT1547. **C**: Rhegmatogenous retinal detachment and paravascular pigmented lattice degeneration in QT1547. **D**: The pigeon chest and protuberant abdomen of QT1553. **E**: The micrognathia of QT1589 and QT1791 compared to the mandibular protrusion of QT1553 and HM964. **F**: Bone retardation in the wrist of QT1589.](mv-v22-697-f2){#f2}

Discussion
==========

In this study, we detected five *COL2A1* mutations in six of 16 Chinese probands with Stickler syndrome, including three novel and two known mutations. All three novel mutations were premature termination codons. The two known variants were heterozygous missense mutations that involved arginine changed to cysteine in the X position of the Gly-X-Y triple helix.

The stop and frameshift mutations leading to nonsense-mediated decay are typical and common mutation types reported in type 1 Stickler syndrome \[[@r4]\]. The mutation of arginine to cysteine in the X position of Gly-X-Y is significant in patients with initial ocular phenotypes. Our findings differ from previous reports in which the most common missense mutation in the helix was the glycine substitution in Gly-X-Y repeating motifs of *COL2A1* in Caucasians \[[@r20]\]. According to the Human Gene Mutation Database, 81.8% (193/236) of missense mutations of *COL2A1* are substitutions of glycine ([HGMD](http://www.hgmd.cf.ac.uk/ac/index.php), last updated in March 2015). Glycine substitutions in Gly-X-Y repeating motifs can lead to more serious systemic phenotypes, such as chondrodysplasias and spondyloepiphyseal dysplasia in Caucasian and Chinese individuals \[[@r8],[@r21]-[@r23]\]. For patients with truncations and other types of missense mutations, the systemic phenotype may be mild. In this study, three of the six patients with mutations of *COL2A1* had missense mutations of arginine changed to cysteine. Nevertheless, due to the small sample size of the study, the importance of arginine changed to cysteine in Chinese patients with Stickler syndrome initially diagnosed in the ophthalmic department must be qualified pending further larger-scale studies.

According to a previous study, nearly three quarters of patients with Stickler syndrome have significant refractive error \[[@r24]\]. In this study, the ratio was much higher in the patients who came to the ophthalmic department. The early onset of moderate or high myopia (\<--4.00 D) was found in 93.8% of patients (15/16). All eight children diagnosed under the age of 6 years had an initial symptom of myopia; of these patients, 87.5% (7/8) had bilateral severe myopia greater than −10.00 D (six patients), and QT851 had secondary bilateral retinal detachment. In comparison to the serious ocular anomalies, the systemic phenotypes were relatively mild. All children had a typical flat face with prominent eyes and a low nasal bridge. Only QT1553 had an obvious pigeon chest. QT1589 and HM964 had epiphyseal dysplasia and precocious osteoarthrosis in both wrists based on X-ray without complaints. None of the children had hearing loss. According to Sun's study, 14 Chinese patients with mutations of *COL2A1* or *COL11A1* were detected with exome sequencing in 298 probands with an initial diagnosis of early-onset high myopia \[[@r25]\]. Several patients with Stickler syndrome had a missed diagnosis under the outstanding phenotype of myopia. Diagnosis in young children is more difficult because the phenotype evolves over the lifetime, particularly in sporadic cases. Early-onset high myopia with vitreous abnormalities may be a key indicator of Stickler syndrome, particularly for those worse than −10.00 D. The early diagnosis of Stickler syndrome is essential for its specific management, such as prophylactic cryotherapy, to protect the eyes from retinal detachment \[[@r3],[@r5],[@r6]\]. Gene detection is also useful as an auxiliary diagnosis, particularly for high-myopia children with a family history.

Compared to adults, characteristic facial phenotypes are more typical in children \[[@r9]\]. Interestingly, in this study, all children with a detected mutation in *COL2A1* had micrognathia, while two children who had an absence of mutation in *COL2A1* and *COL11A1* showed a mandibular protrusion. The existence of mandibular protrusion in pediatric patients may be an efficient indicator of the absence of mutations in *COL2A1* and *COL11A1*. However, the sample size was limited, and more studies in young Chinese patients are necessary to confirm this result.

In this study, the efficiency of mutation detection of *COL2A1* (37.5%) was between the range of Liberfarb et al. (15.6%) and Hoornaert et al. (53.2%) and was limited compared to Richards et al. (96.5%) \[[@r4],[@r8],[@r9]\]. The main reason for this difference may be the lack of candidate gene selection based on the type of vitreous anomalies. In this study, all vitreous anomalies of patients were confirmed with a B-scan. However, due to a history of cataracts, vitrectomy or eyeball atrophy, and the noncooperation of children, it was difficult to clearly classify the type of vitreous anomaly in some patients. Second, the genetic screening of *COL2A1* and *COL11A1* was performed with Sanger sequencing and MLPA. Due to the limitations of the methodology used, large-scale genomic rearrangements could not be excluded. According to Richards et al. \[[@r26]\], deep intronic mutations that result in multiple transcripts can also be an important finding in type 1 and 2 disease. Moreover, mutations in *COL2A1* and *COL11A1* cannot be completely excluded in *COL2A1*- or *COL11A1*-negative patients. Third, the mild systemic phenotype made the classification of Stickler syndrome more difficult, and less obvious hearing loss, cleft palate, or arthropathy may lead to misdiagnosis. Thus, the accurate diagnosis of Stickler syndrome remains a challenge for ophthalmologists. In addition to these reasons, other candidate genes for Stickler syndrome may remain. To identify a new candidate gene, linkage analysis must be performed in families without detected mutations.

In summary, we analyzed the *COL2A1* and *COL11A1* genes in Chinese patients with Stickler syndrome and detected five different mutations, including three novel ones, which expand the spectrum of *COL2A1* genes. This is the first study in a cohort of Chinese patients with Stickler syndrome, and *COL2A1* is also the main candidate gene in Chinese individuals. We found that early-onset high myopia is an important phenotype in most patients with Stickler syndrome and that early diagnosis and prevention are overlooked in Chinese patients, particularly in children. The existence of mandibular protrusion in pediatric patients may be an efficient indicator of the absence of mutations in *COL2A1* and *COL11A1*. However, there must be larger-scale studies to reveal the genotype-phenotype correlation of Asian patients with Stickler syndrome.
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